|
WO2017125429A1
|
|
The use of a temporary inhibitor of p53 for preventing or reducing cancer relapse
|
|
WO2017037250A1
|
|
Wearable health and lifestyle device
|
|
EP3247456A1
|
|
System for treatment by photodynamic therapy and method for preparation of such system
|
|
EP3233084A1
|
|
Gsk3b and uses thereof in the diagnostic and treatment of hypopigmentation disorders
|
|
EP3215636A1
|
|
Method for identifying in a subject tumour cells bearing a t315i mutation
|
|
EP3140423A1
|
|
New biomarker for aml
|
|
EP2850207A1
|
|
Methods for the diagnosis and the treatment of familial thoracic aortic aneurysms caused by tgfb2 loss of function mutations
|
|
EP2785335A1
|
|
Methods and pharmaceutical compositions for the treatment of darier disease
|
|
EP2761010A1
|
|
Lentiviral vectors pseudotyped with mutant baev env glycoproteins
|
|
EP2691111A1
|
|
Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
|
